nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2C—choroid plexus—brain cancer	0.0593	0.115	CbGeAlD
Cyproheptadine—HTR2A—choroid plexus—brain cancer	0.0298	0.0575	CbGeAlD
Cyproheptadine—HRH1—nose—brain cancer	0.023	0.0444	CbGeAlD
Cyproheptadine—HTR6—ganglion—brain cancer	0.0187	0.0362	CbGeAlD
Cyproheptadine—HTR2C—telencephalic ventricle—brain cancer	0.0174	0.0336	CbGeAlD
Cyproheptadine—HTR2A—trigeminal nerve—brain cancer	0.015	0.0291	CbGeAlD
Cyproheptadine—HTR2A—cerebellar cortex—brain cancer	0.015	0.029	CbGeAlD
Cyproheptadine—HTR1A—telencephalic ventricle—brain cancer	0.0146	0.0283	CbGeAlD
Cyproheptadine—HTR2A—vein—brain cancer	0.0136	0.0263	CbGeAlD
Cyproheptadine—DRD2—telencephalic ventricle—brain cancer	0.0132	0.0255	CbGeAlD
Cyproheptadine—HTR2C—ganglion—brain cancer	0.0108	0.0209	CbGeAlD
Cyproheptadine—HTR2A—cranial nerve—brain cancer	0.0107	0.0207	CbGeAlD
Cyproheptadine—HTR2A—pons—brain cancer	0.0106	0.0205	CbGeAlD
Cyproheptadine—HTR1A—ganglion—brain cancer	0.0091	0.0176	CbGeAlD
Cyproheptadine—SLC6A2—ganglion—brain cancer	0.00903	0.0174	CbGeAlD
Cyproheptadine—HTR2A—telencephalic ventricle—brain cancer	0.00872	0.0168	CbGeAlD
Cyproheptadine—DRD2—ganglion—brain cancer	0.00823	0.0159	CbGeAlD
Cyproheptadine—UGT1A3—endocrine gland—brain cancer	0.00781	0.0151	CbGeAlD
Cyproheptadine—HTR2A—pineal body—brain cancer	0.00756	0.0146	CbGeAlD
Cyproheptadine—Photosensitivity—Procarbazine—brain cancer	0.00737	0.017	CcSEcCtD
Cyproheptadine—HTR6—telencephalon—brain cancer	0.00722	0.014	CbGeAlD
Cyproheptadine—Haemolytic anaemia—Procarbazine—brain cancer	0.00717	0.0166	CcSEcCtD
Cyproheptadine—Cholestasis—Temozolomide—brain cancer	0.0071	0.0164	CcSEcCtD
Cyproheptadine—HTR1A—hindbrain—brain cancer	0.00691	0.0133	CbGeAlD
Cyproheptadine—Diplopia—Procarbazine—brain cancer	0.00647	0.0149	CcSEcCtD
Cyproheptadine—DRD2—hindbrain—brain cancer	0.00624	0.0121	CbGeAlD
Cyproheptadine—Hepatic failure—Hydroxyurea—brain cancer	0.00557	0.0129	CcSEcCtD
Cyproheptadine—Leukopenia—Lomustine—brain cancer	0.0055	0.0127	CcSEcCtD
Cyproheptadine—Sweating increased—Procarbazine—brain cancer	0.00545	0.0126	CcSEcCtD
Cyproheptadine—HTR2A—ganglion—brain cancer	0.00543	0.0105	CbGeAlD
Cyproheptadine—Pollakiuria—Procarbazine—brain cancer	0.00517	0.0119	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Procarbazine—brain cancer	0.00511	0.0118	CcSEcCtD
Cyproheptadine—Drowsiness—Procarbazine—brain cancer	0.00499	0.0115	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Lomustine—brain cancer	0.00491	0.0113	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Procarbazine—brain cancer	0.00489	0.0113	CcSEcCtD
Cyproheptadine—Chest discomfort—Etoposide—brain cancer	0.00488	0.0113	CcSEcCtD
Cyproheptadine—Jaundice—Procarbazine—brain cancer	0.00486	0.0112	CcSEcCtD
Cyproheptadine—Anorexia—Lomustine—brain cancer	0.00478	0.011	CcSEcCtD
Cyproheptadine—HTR2C—brainstem—brain cancer	0.0047	0.00909	CbGeAlD
Cyproheptadine—HTR2A—endothelium—brain cancer	0.00468	0.00904	CbGeAlD
Cyproheptadine—HTR6—head—brain cancer	0.0045	0.00869	CbGeAlD
Cyproheptadine—Hallucination—Procarbazine—brain cancer	0.00446	0.0103	CcSEcCtD
Cyproheptadine—Decreased appetite—Lomustine—brain cancer	0.00436	0.0101	CcSEcCtD
Cyproheptadine—Hepatic failure—Temozolomide—brain cancer	0.00435	0.0101	CcSEcCtD
Cyproheptadine—CHRM2—telencephalon—brain cancer	0.00433	0.00837	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—brain cancer	0.00431	0.00834	CbGeAlD
Cyproheptadine—Nasal congestion—Temozolomide—brain cancer	0.0043	0.00992	CcSEcCtD
Cyproheptadine—HTR2C—telencephalon—brain cancer	0.00417	0.00806	CbGeAlD
Cyproheptadine—HTR2A—hindbrain—brain cancer	0.00412	0.00795	CbGeAlD
Cyproheptadine—HTR6—central nervous system—brain cancer	0.0041	0.00793	CbGeAlD
Cyproheptadine—Diplopia—Carmustine—brain cancer	0.00405	0.00935	CcSEcCtD
Cyproheptadine—Chills—Procarbazine—brain cancer	0.00402	0.00927	CcSEcCtD
Cyproheptadine—HTR1A—brainstem—brain cancer	0.00396	0.00765	CbGeAlD
Cyproheptadine—CHRM1—telencephalon—brain cancer	0.00394	0.00762	CbGeAlD
Cyproheptadine—Weight increased—Hydroxyurea—brain cancer	0.00394	0.0091	CcSEcCtD
Cyproheptadine—SLC6A2—brainstem—brain cancer	0.00392	0.00758	CbGeAlD
Cyproheptadine—HTR2B—telencephalon—brain cancer	0.00392	0.00758	CbGeAlD
Cyproheptadine—Diplopia—Temozolomide—brain cancer	0.00391	0.00903	CcSEcCtD
Cyproheptadine—Drowsiness—Hydroxyurea—brain cancer	0.00386	0.00891	CcSEcCtD
Cyproheptadine—Cyclizine—CYP2C9—brain cancer	0.00384	0.34	CrCbGaD
Cyproheptadine—Tension—Procarbazine—brain cancer	0.00382	0.00883	CcSEcCtD
Cyproheptadine—Nervousness—Procarbazine—brain cancer	0.00379	0.00874	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00378	0.00874	CcSEcCtD
Cyproheptadine—Tremor—Procarbazine—brain cancer	0.00365	0.00843	CcSEcCtD
Cyproheptadine—DRD2—brainstem—brain cancer	0.00358	0.00691	CbGeAlD
Cyproheptadine—CHRM3—telencephalon—brain cancer	0.00353	0.00682	CbGeAlD
Cyproheptadine—HTR1A—telencephalon—brain cancer	0.00351	0.00679	CbGeAlD
Cyproheptadine—Syncope—Procarbazine—brain cancer	0.0035	0.00807	CcSEcCtD
Cyproheptadine—Leukopenia—Procarbazine—brain cancer	0.00349	0.00805	CcSEcCtD
Cyproheptadine—SLC6A2—telencephalon—brain cancer	0.00348	0.00673	CbGeAlD
Cyproheptadine—Hallucination—Hydroxyurea—brain cancer	0.00345	0.00796	CcSEcCtD
Cyproheptadine—Loss of consciousness—Procarbazine—brain cancer	0.00343	0.00791	CcSEcCtD
Cyproheptadine—Convulsion—Procarbazine—brain cancer	0.00338	0.0078	CcSEcCtD
Cyproheptadine—Sweating increased—Temozolomide—brain cancer	0.00329	0.00761	CcSEcCtD
Cyproheptadine—HTR2C—medulla oblongata—brain cancer	0.00328	0.00634	CbGeAlD
Cyproheptadine—HTR6—brain—brain cancer	0.00326	0.0063	CbGeAlD
Cyproheptadine—Confusional state—Procarbazine—brain cancer	0.00321	0.0074	CcSEcCtD
Cyproheptadine—Vomiting—Lomustine—brain cancer	0.00319	0.00735	CcSEcCtD
Cyproheptadine—Oedema—Procarbazine—brain cancer	0.00318	0.00734	CcSEcCtD
Cyproheptadine—DRD2—telencephalon—brain cancer	0.00317	0.00613	CbGeAlD
Cyproheptadine—Shock—Procarbazine—brain cancer	0.00313	0.00723	CcSEcCtD
Cyproheptadine—Pollakiuria—Temozolomide—brain cancer	0.00312	0.00721	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Procarbazine—brain cancer	0.00311	0.00719	CcSEcCtD
Cyproheptadine—Chills—Hydroxyurea—brain cancer	0.00311	0.00718	CcSEcCtD
Cyproheptadine—Tachycardia—Procarbazine—brain cancer	0.0031	0.00717	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Temozolomide—brain cancer	0.00309	0.00713	CcSEcCtD
Cyproheptadine—Weight increased—Temozolomide—brain cancer	0.00308	0.00711	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Procarbazine—brain cancer	0.00308	0.0071	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Carmustine—brain cancer	0.00306	0.00706	CcSEcCtD
Cyproheptadine—Anorexia—Procarbazine—brain cancer	0.00303	0.007	CcSEcCtD
Cyproheptadine—HTR2C—midbrain—brain cancer	0.003	0.00579	CbGeAlD
Cyproheptadine—Nausea—Lomustine—brain cancer	0.00298	0.00687	CcSEcCtD
Cyproheptadine—Hypotension—Procarbazine—brain cancer	0.00297	0.00686	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Temozolomide—brain cancer	0.00296	0.00682	CcSEcCtD
Cyproheptadine—HTR2C—spinal cord—brain cancer	0.00292	0.00565	CbGeAlD
Cyproheptadine—SLC6A2—gonad—brain cancer	0.00291	0.00562	CbGeAlD
Cyproheptadine—Insomnia—Procarbazine—brain cancer	0.00288	0.00664	CcSEcCtD
Cyproheptadine—Paraesthesia—Procarbazine—brain cancer	0.00286	0.00659	CcSEcCtD
Cyproheptadine—Somnolence—Procarbazine—brain cancer	0.00283	0.00653	CcSEcCtD
Cyproheptadine—Hallucination—Carmustine—brain cancer	0.00279	0.00643	CcSEcCtD
Cyproheptadine—Decreased appetite—Procarbazine—brain cancer	0.00277	0.00638	CcSEcCtD
Cyproheptadine—Fatigue—Procarbazine—brain cancer	0.00274	0.00633	CcSEcCtD
Cyproheptadine—SLC6A2—medulla oblongata—brain cancer	0.00274	0.00529	CbGeAlD
Cyproheptadine—CHRM2—endocrine gland—brain cancer	0.00273	0.00528	CbGeAlD
Cyproheptadine—Constipation—Procarbazine—brain cancer	0.00272	0.00628	CcSEcCtD
Cyproheptadine—Hepatitis—Temozolomide—brain cancer	0.00271	0.00625	CcSEcCtD
Cyproheptadine—Leukopenia—Hydroxyurea—brain cancer	0.0027	0.00623	CcSEcCtD
Cyproheptadine—CHRM2—head—brain cancer	0.0027	0.00521	CbGeAlD
Cyproheptadine—Hallucination—Temozolomide—brain cancer	0.00269	0.00622	CcSEcCtD
Cyproheptadine—Sweating increased—Etoposide—brain cancer	0.00264	0.00609	CcSEcCtD
Cyproheptadine—Feeling abnormal—Procarbazine—brain cancer	0.00262	0.00605	CcSEcCtD
Cyproheptadine—Convulsion—Hydroxyurea—brain cancer	0.00261	0.00603	CcSEcCtD
Cyproheptadine—HTR2C—head—brain cancer	0.0026	0.00502	CbGeAlD
Cyproheptadine—DRD2—pituitary gland—brain cancer	0.00258	0.00499	CbGeAlD
Cyproheptadine—Urticaria—Procarbazine—brain cancer	0.00253	0.00583	CcSEcCtD
Cyproheptadine—Tinnitus—Temozolomide—brain cancer	0.00252	0.00583	CcSEcCtD
Cyproheptadine—HTR1A—midbrain—brain cancer	0.00252	0.00487	CbGeAlD
Cyproheptadine—HRH1—telencephalon—brain cancer	0.00251	0.00484	CbGeAlD
Cyproheptadine—CHRM1—endocrine gland—brain cancer	0.00249	0.0048	CbGeAlD
Cyproheptadine—Carbamazepine—CYP2C9—brain cancer	0.00247	0.219	CrCbGaD
Cyproheptadine—Oedema—Hydroxyurea—brain cancer	0.00246	0.00568	CcSEcCtD
Cyproheptadine—HTR1A—spinal cord—brain cancer	0.00246	0.00476	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—brain cancer	0.00246	0.00476	CbGeAlD
Cyproheptadine—CHRM1—head—brain cancer	0.00245	0.00474	CbGeAlD
Cyproheptadine—HTR2B—head—brain cancer	0.00244	0.00472	CbGeAlD
Cyproheptadine—Chills—Temozolomide—brain cancer	0.00243	0.00561	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00241	0.00556	CcSEcCtD
Cyproheptadine—HTR2C—central nervous system—brain cancer	0.00237	0.00458	CbGeAlD
Cyproheptadine—Neuropathy peripheral—Etoposide—brain cancer	0.00237	0.00546	CcSEcCtD
Cyproheptadine—HTR2A—brainstem—brain cancer	0.00236	0.00456	CbGeAlD
Cyproheptadine—Jaundice—Etoposide—brain cancer	0.00235	0.00543	CcSEcCtD
Cyproheptadine—Anorexia—Hydroxyurea—brain cancer	0.00235	0.00542	CcSEcCtD
Cyproheptadine—Vision blurred—Carmustine—brain cancer	0.0023	0.00531	CcSEcCtD
Cyproheptadine—Tremor—Carmustine—brain cancer	0.00228	0.00527	CcSEcCtD
Cyproheptadine—Asthenia—Procarbazine—brain cancer	0.00228	0.00527	CcSEcCtD
Cyproheptadine—DRD2—midbrain—brain cancer	0.00228	0.0044	CbGeAlD
Cyproheptadine—Agranulocytosis—Etoposide—brain cancer	0.00225	0.0052	CcSEcCtD
Cyproheptadine—Agitation—Carmustine—brain cancer	0.00224	0.00517	CcSEcCtD
Cyproheptadine—CHRM1—central nervous system—brain cancer	0.00224	0.00433	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—brain cancer	0.00223	0.00431	CbGeAlD
Cyproheptadine—CHRM3—endocrine gland—brain cancer	0.00222	0.0043	CbGeAlD
Cyproheptadine—Vision blurred—Temozolomide—brain cancer	0.00222	0.00513	CcSEcCtD
Cyproheptadine—HTR1A—endocrine gland—brain cancer	0.00222	0.00428	CbGeAlD
Cyproheptadine—Tremor—Temozolomide—brain cancer	0.00221	0.0051	CcSEcCtD
Cyproheptadine—SLC6A2—endocrine gland—brain cancer	0.0022	0.00425	CbGeAlD
Cyproheptadine—CHRM3—head—brain cancer	0.0022	0.00424	CbGeAlD
Cyproheptadine—Somnolence—Hydroxyurea—brain cancer	0.00219	0.00505	CcSEcCtD
Cyproheptadine—HTR1A—head—brain cancer	0.00219	0.00423	CbGeAlD
Cyproheptadine—Leukopenia—Carmustine—brain cancer	0.00218	0.00504	CcSEcCtD
Cyproheptadine—Diarrhoea—Procarbazine—brain cancer	0.00218	0.00502	CcSEcCtD
Cyproheptadine—SLC6A2—head—brain cancer	0.00217	0.00419	CbGeAlD
Cyproheptadine—Dyspepsia—Hydroxyurea—brain cancer	0.00217	0.005	CcSEcCtD
Cyproheptadine—Agitation—Temozolomide—brain cancer	0.00217	0.005	CcSEcCtD
Cyproheptadine—Decreased appetite—Hydroxyurea—brain cancer	0.00214	0.00494	CcSEcCtD
Cyproheptadine—Fatigue—Hydroxyurea—brain cancer	0.00212	0.0049	CcSEcCtD
Cyproheptadine—Vertigo—Temozolomide—brain cancer	0.00212	0.00489	CcSEcCtD
Cyproheptadine—Convulsion—Carmustine—brain cancer	0.00211	0.00488	CcSEcCtD
Cyproheptadine—Leukopenia—Temozolomide—brain cancer	0.00211	0.00487	CcSEcCtD
Cyproheptadine—Constipation—Hydroxyurea—brain cancer	0.00211	0.00486	CcSEcCtD
Cyproheptadine—Dizziness—Procarbazine—brain cancer	0.0021	0.00486	CcSEcCtD
Cyproheptadine—HTR2A—telencephalon—brain cancer	0.00209	0.00405	CbGeAlD
Cyproheptadine—Palpitations—Temozolomide—brain cancer	0.00208	0.00481	CcSEcCtD
Cyproheptadine—Convulsion—Temozolomide—brain cancer	0.00204	0.00471	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP2C9—brain cancer	0.00204	0.18	CrCbGaD
Cyproheptadine—Feeling abnormal—Hydroxyurea—brain cancer	0.00203	0.00468	CcSEcCtD
Cyproheptadine—Vomiting—Procarbazine—brain cancer	0.00202	0.00467	CcSEcCtD
Cyproheptadine—Confusional state—Carmustine—brain cancer	0.00201	0.00463	CcSEcCtD
Cyproheptadine—Rash—Procarbazine—brain cancer	0.00201	0.00463	CcSEcCtD
Cyproheptadine—CHRM3—central nervous system—brain cancer	0.002	0.00387	CbGeAlD
Cyproheptadine—Dermatitis—Procarbazine—brain cancer	0.002	0.00463	CcSEcCtD
Cyproheptadine—DRD2—endocrine gland—brain cancer	0.002	0.00387	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—brain cancer	0.002	0.00386	CbGeAlD
Cyproheptadine—Headache—Procarbazine—brain cancer	0.00199	0.0046	CcSEcCtD
Cyproheptadine—Oedema—Carmustine—brain cancer	0.00199	0.00459	CcSEcCtD
Cyproheptadine—SLC6A2—central nervous system—brain cancer	0.00198	0.00383	CbGeAlD
Cyproheptadine—DRD2—head—brain cancer	0.00198	0.00382	CbGeAlD
Cyproheptadine—CHRM2—brain—brain cancer	0.00195	0.00378	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—brain cancer	0.00195	0.00377	CbGeAlD
Cyproheptadine—Thrombocytopenia—Carmustine—brain cancer	0.00195	0.0045	CcSEcCtD
Cyproheptadine—Chills—Etoposide—brain cancer	0.00194	0.00449	CcSEcCtD
Cyproheptadine—Tachycardia—Carmustine—brain cancer	0.00194	0.00448	CcSEcCtD
Cyproheptadine—Confusional state—Temozolomide—brain cancer	0.00194	0.00448	CcSEcCtD
Cyproheptadine—Oedema—Temozolomide—brain cancer	0.00192	0.00444	CcSEcCtD
Cyproheptadine—Anorexia—Carmustine—brain cancer	0.0019	0.00438	CcSEcCtD
Cyproheptadine—Nausea—Procarbazine—brain cancer	0.00189	0.00436	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Temozolomide—brain cancer	0.00188	0.00435	CcSEcCtD
Cyproheptadine—HTR2C—brain—brain cancer	0.00188	0.00364	CbGeAlD
Cyproheptadine—Hypotension—Carmustine—brain cancer	0.00186	0.00429	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Temozolomide—brain cancer	0.00186	0.00429	CcSEcCtD
Cyproheptadine—Anorexia—Temozolomide—brain cancer	0.00183	0.00423	CcSEcCtD
Cyproheptadine—DRD2—central nervous system—brain cancer	0.0018	0.00349	CbGeAlD
Cyproheptadine—Insomnia—Carmustine—brain cancer	0.0018	0.00416	CcSEcCtD
Cyproheptadine—Paraesthesia—Carmustine—brain cancer	0.00179	0.00413	CcSEcCtD
Cyproheptadine—CHRM1—brain—brain cancer	0.00178	0.00344	CbGeAlD
Cyproheptadine—Somnolence—Carmustine—brain cancer	0.00177	0.00408	CcSEcCtD
Cyproheptadine—HTR2B—brain—brain cancer	0.00177	0.00342	CbGeAlD
Cyproheptadine—Asthenia—Hydroxyurea—brain cancer	0.00177	0.00408	CcSEcCtD
Cyproheptadine—DRD2—cerebellum—brain cancer	0.00176	0.00341	CbGeAlD
Cyproheptadine—HTR2A—gonad—brain cancer	0.00175	0.00338	CbGeAlD
Cyproheptadine—Insomnia—Temozolomide—brain cancer	0.00174	0.00402	CcSEcCtD
Cyproheptadine—Decreased appetite—Carmustine—brain cancer	0.00173	0.00399	CcSEcCtD
Cyproheptadine—Paraesthesia—Temozolomide—brain cancer	0.00173	0.00399	CcSEcCtD
Cyproheptadine—Somnolence—Temozolomide—brain cancer	0.00171	0.00395	CcSEcCtD
Cyproheptadine—HTR2A—pituitary gland—brain cancer	0.0017	0.00329	CbGeAlD
Cyproheptadine—Constipation—Carmustine—brain cancer	0.0017	0.00393	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—brain cancer	0.00169	0.00391	CcSEcCtD
Cyproheptadine—Dyspepsia—Temozolomide—brain cancer	0.00169	0.00391	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—brain cancer	0.00169	0.0039	CcSEcCtD
Cyproheptadine—Diarrhoea—Hydroxyurea—brain cancer	0.00168	0.00389	CcSEcCtD
Cyproheptadine—Decreased appetite—Temozolomide—brain cancer	0.00167	0.00386	CcSEcCtD
Cyproheptadine—Fatigue—Temozolomide—brain cancer	0.00166	0.00383	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—brain cancer	0.00166	0.00383	CcSEcCtD
Cyproheptadine—Constipation—Temozolomide—brain cancer	0.00164	0.0038	CcSEcCtD
Cyproheptadine—HTR2A—medulla oblongata—brain cancer	0.00164	0.00318	CbGeAlD
Cyproheptadine—Feeling abnormal—Carmustine—brain cancer	0.00164	0.00379	CcSEcCtD
Cyproheptadine—Convulsion—Etoposide—brain cancer	0.00163	0.00377	CcSEcCtD
Cyproheptadine—Dizziness—Hydroxyurea—brain cancer	0.00163	0.00376	CcSEcCtD
Cyproheptadine—CHRM3—brain—brain cancer	0.00159	0.00308	CbGeAlD
Cyproheptadine—Feeling abnormal—Temozolomide—brain cancer	0.00158	0.00366	CcSEcCtD
Cyproheptadine—HTR1A—brain—brain cancer	0.00158	0.00306	CbGeAlD
Cyproheptadine—HRH1—endocrine gland—brain cancer	0.00158	0.00306	CbGeAlD
Cyproheptadine—SLC6A2—brain—brain cancer	0.00157	0.00304	CbGeAlD
Cyproheptadine—Vomiting—Hydroxyurea—brain cancer	0.00157	0.00361	CcSEcCtD
Cyproheptadine—HRH1—head—brain cancer	0.00156	0.00302	CbGeAlD
Cyproheptadine—Rash—Hydroxyurea—brain cancer	0.00155	0.00358	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—brain cancer	0.00155	0.00358	CcSEcCtD
Cyproheptadine—Dermatitis—Hydroxyurea—brain cancer	0.00155	0.00358	CcSEcCtD
Cyproheptadine—Headache—Hydroxyurea—brain cancer	0.00154	0.00356	CcSEcCtD
Cyproheptadine—Urticaria—Temozolomide—brain cancer	0.00153	0.00353	CcSEcCtD
Cyproheptadine—Clozapine—CYP2C9—brain cancer	0.00152	0.135	CrCbGaD
Cyproheptadine—Thrombocytopenia—Etoposide—brain cancer	0.00151	0.00348	CcSEcCtD
Cyproheptadine—HTR2A—midbrain—brain cancer	0.0015	0.00291	CbGeAlD
Cyproheptadine—Tachycardia—Etoposide—brain cancer	0.0015	0.00347	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—brain cancer	0.00149	0.00343	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—brain cancer	0.00147	0.00339	CcSEcCtD
Cyproheptadine—HTR2A—spinal cord—brain cancer	0.00147	0.00283	CbGeAlD
Cyproheptadine—Nausea—Hydroxyurea—brain cancer	0.00146	0.00338	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—brain cancer	0.00144	0.00332	CcSEcCtD
Cyproheptadine—DRD2—brain—brain cancer	0.00143	0.00277	CbGeAlD
Cyproheptadine—Asthenia—Carmustine—brain cancer	0.00143	0.0033	CcSEcCtD
Cyproheptadine—HRH1—central nervous system—brain cancer	0.00142	0.00275	CbGeAlD
Cyproheptadine—Amitriptyline—CYP2C9—brain cancer	0.00141	0.125	CrCbGaD
Cyproheptadine—Paraesthesia—Etoposide—brain cancer	0.00138	0.00319	CcSEcCtD
Cyproheptadine—Asthenia—Temozolomide—brain cancer	0.00138	0.00319	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—brain cancer	0.00137	0.00316	CcSEcCtD
Cyproheptadine—Diarrhoea—Carmustine—brain cancer	0.00136	0.00314	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—brain cancer	0.00134	0.00309	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—brain cancer	0.00133	0.00306	CcSEcCtD
Cyproheptadine—HTR2A—endocrine gland—brain cancer	0.00132	0.00255	CbGeAlD
Cyproheptadine—Dizziness—Carmustine—brain cancer	0.00132	0.00304	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—brain cancer	0.00132	0.00304	CcSEcCtD
Cyproheptadine—Diarrhoea—Temozolomide—brain cancer	0.00132	0.00304	CcSEcCtD
Cyproheptadine—HTR2A—head—brain cancer	0.0013	0.00252	CbGeAlD
Cyproheptadine—Dizziness—Temozolomide—brain cancer	0.00127	0.00294	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—brain cancer	0.00127	0.00293	CcSEcCtD
Cyproheptadine—Vomiting—Carmustine—brain cancer	0.00127	0.00292	CcSEcCtD
Cyproheptadine—Rash—Carmustine—brain cancer	0.00125	0.0029	CcSEcCtD
Cyproheptadine—Dermatitis—Carmustine—brain cancer	0.00125	0.00289	CcSEcCtD
Cyproheptadine—Headache—Carmustine—brain cancer	0.00125	0.00288	CcSEcCtD
Cyproheptadine—Vomiting—Temozolomide—brain cancer	0.00122	0.00282	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—brain cancer	0.00122	0.00282	CcSEcCtD
Cyproheptadine—Rash—Temozolomide—brain cancer	0.00121	0.0028	CcSEcCtD
Cyproheptadine—Dermatitis—Temozolomide—brain cancer	0.00121	0.0028	CcSEcCtD
Cyproheptadine—Headache—Temozolomide—brain cancer	0.0012	0.00278	CcSEcCtD
Cyproheptadine—HTR2A—central nervous system—brain cancer	0.00119	0.0023	CbGeAlD
Cyproheptadine—Nausea—Carmustine—brain cancer	0.00118	0.00273	CcSEcCtD
Cyproheptadine—HTR2A—cerebellum—brain cancer	0.00116	0.00225	CbGeAlD
Cyproheptadine—Nausea—Temozolomide—brain cancer	0.00114	0.00264	CcSEcCtD
Cyproheptadine—HRH1—brain—brain cancer	0.00113	0.00219	CbGeAlD
Cyproheptadine—Asthenia—Etoposide—brain cancer	0.0011	0.00255	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—brain cancer	0.00105	0.00243	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—brain cancer	0.00102	0.00235	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—brain cancer	0.000979	0.00226	CcSEcCtD
Cyproheptadine—Rash—Etoposide—brain cancer	0.00097	0.00224	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—brain cancer	0.00097	0.00224	CcSEcCtD
Cyproheptadine—Headache—Etoposide—brain cancer	0.000964	0.00223	CcSEcCtD
Cyproheptadine—HTR2A—brain—brain cancer	0.000945	0.00183	CbGeAlD
Cyproheptadine—Nausea—Etoposide—brain cancer	0.000914	0.00211	CcSEcCtD
Cyproheptadine—UGT1A3—Metabolism—PIK3CG—brain cancer	2.42e-05	0.000636	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOTCH2—brain cancer	2.41e-05	0.000632	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VAV1—brain cancer	2.3e-05	0.000602	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SHH—brain cancer	2.26e-05	0.000593	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SHH—brain cancer	2.23e-05	0.000584	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SHH—brain cancer	2.22e-05	0.000583	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SHH—brain cancer	2.21e-05	0.000581	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SHH—brain cancer	2.21e-05	0.000579	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	2.2e-05	0.000578	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.19e-05	0.000575	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SHH—brain cancer	2.19e-05	0.000573	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TRPC6—brain cancer	2.18e-05	0.000572	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HES1—brain cancer	2.16e-05	0.000567	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TRPC6—brain cancer	2.15e-05	0.000563	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTCH1—brain cancer	2.14e-05	0.000562	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SMO—brain cancer	2.14e-05	0.000562	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TRPC6—brain cancer	2.14e-05	0.000562	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TRPC6—brain cancer	2.14e-05	0.00056	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TRPC6—brain cancer	2.13e-05	0.000558	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SMO—brain cancer	2.11e-05	0.000553	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTCH1—brain cancer	2.11e-05	0.000553	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TRPC6—brain cancer	2.11e-05	0.000553	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SMO—brain cancer	2.11e-05	0.000552	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTCH1—brain cancer	2.11e-05	0.000552	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTCH1—brain cancer	2.1e-05	0.00055	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SMO—brain cancer	2.1e-05	0.00055	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—IL2—brain cancer	2.09e-05	0.000549	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTCH1—brain cancer	2.09e-05	0.000549	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SMO—brain cancer	2.09e-05	0.000549	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SMO—brain cancer	2.07e-05	0.000543	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTCH1—brain cancer	2.07e-05	0.000543	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PDGFRA—brain cancer	2.06e-05	0.00054	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	2e-05	0.000525	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SPP1—brain cancer	2e-05	0.000524	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.99e-05	0.000522	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HES1—brain cancer	1.97e-05	0.000518	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.95e-05	0.000512	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.94e-05	0.00051	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.93e-05	0.000507	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.91e-05	0.000501	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.9e-05	0.000499	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL2—brain cancer	1.9e-05	0.000499	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.9e-05	0.000498	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.89e-05	0.000497	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	1.89e-05	0.000495	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.88e-05	0.000493	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.87e-05	0.00049	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VAV1—brain cancer	1.86e-05	0.000488	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VAV1—brain cancer	1.85e-05	0.000486	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SPP1—brain cancer	1.83e-05	0.000479	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IRS2—brain cancer	1.81e-05	0.000474	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.76e-05	0.000461	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL2—brain cancer	1.74e-05	0.000455	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.73e-05	0.000453	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.73e-05	0.000452	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.72e-05	0.000451	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.71e-05	0.00045	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.71e-05	0.00045	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.7e-05	0.000445	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.69e-05	0.000442	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.68e-05	0.000441	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.68e-05	0.00044	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.67e-05	0.000439	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.66e-05	0.000434	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IRS2—brain cancer	1.65e-05	0.000433	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VAV1—brain cancer	1.63e-05	0.000429	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.61e-05	0.000422	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VAV1—brain cancer	1.6e-05	0.000421	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HES1—brain cancer	1.6e-05	0.00042	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VAV1—brain cancer	1.6e-05	0.00042	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—APC—brain cancer	1.6e-05	0.000419	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.6e-05	0.000419	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VAV1—brain cancer	1.59e-05	0.000418	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HES1—brain cancer	1.59e-05	0.000418	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.58e-05	0.000414	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.55e-05	0.000407	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.54e-05	0.000405	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.52e-05	0.0004	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.52e-05	0.000398	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SPP1—brain cancer	1.48e-05	0.000388	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.47e-05	0.000386	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.46e-05	0.000382	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APC—brain cancer	1.46e-05	0.000382	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—EGFR—brain cancer	1.46e-05	0.000382	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL2—brain cancer	1.41e-05	0.000369	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HES1—brain cancer	1.41e-05	0.000369	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL2—brain cancer	1.4e-05	0.000367	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000363	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000362	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000361	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HES1—brain cancer	1.37e-05	0.00036	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—IL2—brain cancer	1.36e-05	0.000357	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000356	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000351	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.34e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IRS2—brain cancer	1.34e-05	0.000351	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000351	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.33e-05	0.000349	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IRS2—brain cancer	1.33e-05	0.000349	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.33e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.33e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.32e-05	0.000345	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000345	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.31e-05	0.000345	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.31e-05	0.000344	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.31e-05	0.000342	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SPP1—brain cancer	1.3e-05	0.000341	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	0.000339	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.000335	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.000335	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SPP1—brain cancer	1.27e-05	0.000334	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SPP1—brain cancer	1.27e-05	0.000332	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SPP1—brain cancer	1.26e-05	0.000329	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—RELA—brain cancer	1.25e-05	0.000327	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—ERBB2—brain cancer	1.24e-05	0.000325	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL2—brain cancer	1.24e-05	0.000324	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.22e-05	0.000319	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL2—brain cancer	1.21e-05	0.000318	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CG—brain cancer	1.21e-05	0.000318	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL2—brain cancer	1.21e-05	0.000317	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL2—brain cancer	1.21e-05	0.000316	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL2—brain cancer	1.19e-05	0.000313	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.00031	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APC—brain cancer	1.18e-05	0.00031	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APC—brain cancer	1.18e-05	0.000308	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.000308	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS2—brain cancer	1.18e-05	0.000308	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.16e-05	0.000303	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS2—brain cancer	1.15e-05	0.000303	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS2—brain cancer	1.15e-05	0.000302	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS2—brain cancer	1.15e-05	0.000301	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RELA—brain cancer	1.14e-05	0.000299	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000298	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.13e-05	0.000297	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—brain cancer	1.12e-05	0.000295	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCND1—brain cancer	1.1e-05	0.000287	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	0.000285	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.08e-05	0.000282	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.07e-05	0.000281	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APC—brain cancer	1.04e-05	0.000272	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.04e-05	0.000272	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—brain cancer	1.03e-05	0.000269	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APC—brain cancer	1.02e-05	0.000268	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APC—brain cancer	1.02e-05	0.000267	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000267	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APC—brain cancer	1.02e-05	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APC—brain cancer	1.01e-05	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.01e-05	0.000266	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1e-05	0.000263	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APC—brain cancer	1e-05	0.000263	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCND1—brain cancer	1e-05	0.000262	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	9.9e-06	0.00026	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—brain cancer	9.55e-06	0.00025	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—brain cancer	9.46e-06	0.000248	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—brain cancer	9.46e-06	0.000248	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.3e-06	0.000244	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—brain cancer	9.28e-06	0.000243	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.25e-06	0.000243	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RELA—brain cancer	9.24e-06	0.000242	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—brain cancer	9.23e-06	0.000242	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RELA—brain cancer	9.19e-06	0.000241	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.18e-06	0.000241	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—brain cancer	9.14e-06	0.00024	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.13e-06	0.000239	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—brain cancer	8.79e-06	0.00023	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—brain cancer	8.72e-06	0.000229	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—brain cancer	8.63e-06	0.000226	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—brain cancer	8.6e-06	0.000225	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—brain cancer	8.32e-06	0.000218	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—brain cancer	8.28e-06	0.000217	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RELA—brain cancer	8.11e-06	0.000213	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—brain cancer	8.11e-06	0.000213	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—brain cancer	8.07e-06	0.000212	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—brain cancer	8.06e-06	0.000211	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.03e-06	0.000211	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—brain cancer	8.02e-06	0.00021	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	7.99e-06	0.00021	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RELA—brain cancer	7.98e-06	0.000209	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RELA—brain cancer	7.96e-06	0.000209	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RELA—brain cancer	7.94e-06	0.000208	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—brain cancer	7.93e-06	0.000208	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—brain cancer	7.91e-06	0.000208	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RELA—brain cancer	7.91e-06	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—brain cancer	7.89e-06	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—brain cancer	7.86e-06	0.000206	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—brain cancer	7.85e-06	0.000206	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RELA—brain cancer	7.84e-06	0.000205	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—brain cancer	7.79e-06	0.000204	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—brain cancer	7.3e-06	0.000192	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—brain cancer	7.22e-06	0.000189	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—brain cancer	7.19e-06	0.000188	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—brain cancer	7.17e-06	0.000188	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—brain cancer	7.15e-06	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—brain cancer	7.13e-06	0.000187	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—brain cancer	7.12e-06	0.000187	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.07e-06	0.000185	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—brain cancer	7.06e-06	0.000185	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.05e-06	0.000185	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.03e-06	0.000184	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—brain cancer	7.01e-06	0.000184	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—brain cancer	7e-06	0.000184	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—brain cancer	6.99e-06	0.000183	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—brain cancer	6.97e-06	0.000183	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—brain cancer	6.96e-06	0.000183	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—brain cancer	6.95e-06	0.000182	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	6.94e-06	0.000182	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CTNNB1—brain cancer	6.92e-06	0.000182	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	6.9e-06	0.000181	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—brain cancer	6.88e-06	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	6.88e-06	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	6.81e-06	0.000179	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—brain cancer	6.59e-06	0.000173	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—brain cancer	6.5e-06	0.000171	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—brain cancer	6.47e-06	0.00017	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—brain cancer	6.36e-06	0.000167	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—brain cancer	6.33e-06	0.000166	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—brain cancer	6.21e-06	0.000163	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—brain cancer	6.15e-06	0.000161	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.11e-06	0.00016	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—brain cancer	6.09e-06	0.00016	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.08e-06	0.000159	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—brain cancer	6.06e-06	0.000159	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—brain cancer	6.05e-06	0.000159	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—brain cancer	6.03e-06	0.000158	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—brain cancer	6.02e-06	0.000158	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—brain cancer	6e-06	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—brain cancer	6e-06	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—brain cancer	5.94e-06	0.000156	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—brain cancer	5.71e-06	0.00015	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—brain cancer	5.62e-06	0.000147	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—brain cancer	5.61e-06	0.000147	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—brain cancer	5.59e-06	0.000147	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—brain cancer	5.59e-06	0.000146	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—brain cancer	5.57e-06	0.000146	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—brain cancer	5.52e-06	0.000145	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—brain cancer	5.5e-06	0.000144	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—brain cancer	5.48e-06	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—brain cancer	5.47e-06	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—brain cancer	5.45e-06	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—brain cancer	5.4e-06	0.000142	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—brain cancer	5.34e-06	0.00014	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—brain cancer	5.31e-06	0.000139	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—brain cancer	4.69e-06	0.000123	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—brain cancer	4.62e-06	0.000121	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—brain cancer	4.61e-06	0.000121	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—brain cancer	4.59e-06	0.00012	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—brain cancer	4.58e-06	0.00012	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—brain cancer	4.53e-06	0.000119	CbGpPWpGaD
